Paul Lountzis recent buys & sells (2026 Q1)
Lountzis Asset Management
Lountzis Asset Management Portfolio Changes
Purchase & sale details
- Portfolio value:
- $272.64M (-$9M)
- Previous value:
- $281.62M
- # of changes:
- 22
- New positions:
- 1
- Reported for:
- 31 Mar 2026 (Q1)
- Latest filing date:
- 07 May 2026
Lountzis Asset Management has disclosed a total of 22 changes to the portfolio in the (2026 Q1) SEC report(s): increased the number of shares of 7, bought 1 totally new, decreased the number of shares of 13 and completely sold out 1 position(s).
What stocks did Paul Lountzis buy in 2026 Q1?
During 2026 Q1 Paul Lountzis has bought 8 securities out of which top 5 purchases (by % change to portfolio) were (ORCL) Oracle Corp (added shares +3.70%), (KNSL) Kinsale Capital Group Inc (new buy), (PCOR) Procore Technologies Inc (added shares +6.26%), (PEP) PepsiCo Inc (added shares +0.11%) and (ABT) Abbott Laboratories (added shares +1.43%).
In the 2026 Q1 report(s) the following changes have been made to the top investments: (BRK-B) Berkshire Hathaway Inc (reduced shares -0.20%), (AMAT) Applied Materials Inc (reduced shares -0.38%), (WFC) Wells Fargo & Company (reduced shares -0.26%), (PGR) Progressive Corp (reduced shares -0.11%) and (GOOGL) Alphabet Inc, CL-A (reduced shares -0.07%).
22 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Kinsale Capital Group Inc
|
new
|
+28,942
|
28,942
|
+3.63%
|
$341.66
|
+7.51%($367.32)
|
3.63%
|
2026 Q1
|
~0.25 years
|
|
|
|
Eli Lilly and Company
|
+6.85%
|
+20
|
312
|
+0.01%
|
$919.77
|
+39.29%($1,281.19)
|
0.11%
|
2025 Q1
|
~1.25 years
|
|
|
|
Procore Technologies Inc
|
+6.26%
|
+6,189
|
105,099
|
+0.13%
|
$57.00
|
+8.58%($61.89)
|
2.20%
|
2024 Q3
|
~1.75 years
|
|
|
|
Microsoft Corp
|
+6.03%
|
+75
|
1,319
|
+0.01%
|
$370.17
|
+43.18%($530.00)
|
0.18%
|
2020 Q2
|
~6.00 years
|
|
|
|
Johnson & Johnson
|
+4.98%
|
+129
|
2,720
|
+0.01%
|
$244.44
|
+8.60%($265.47)
|
0.24%
|
2023 Q1
|
~3.25 years
|
|
|
|
Oracle Corp
|
+3.70%
|
+3,311
|
92,776
|
+0.18%
|
$147.11
|
-14.49%($125.80)
|
5.01%
|
2020 Q2
|
~6.00 years
|
|
|
|
Abbott Laboratories
|
+1.43%
|
+105
|
7,430
|
+0%
|
$102.67
|
+1.33%($104.04)
|
0.28%
|
2020 Q2
|
~6.00 years
|
|
|
|
PepsiCo Inc
|
+0.11%
|
+41
|
38,089
|
+0%
|
$155.29
|
-13.02%($135.07)
|
2.17%
|
2020 Q2
|
~6.00 years
|
|
|
|
Cadence Design Systems Inc
|
-0.00%
|
-1
|
44,229
|
-0%
|
$277.87
|
+16.73%($324.37)
|
4.51%
|
2025 Q1
|
~1.25 years
|
|
|
|
Alphabet Inc, CL-A
|
-0.07%
|
-32
|
48,100
|
-0%
|
$287.56
|
+10.69%($318.30)
|
5.07%
|
2020 Q2
|
~6.00 years
|
|
Insights | News
Insight
—
Consensus shift · 2026 Q1
Insight
—
Consensus shift · 2026 Q1
Insight
—
Consensus shift · 2026 Q1
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".